By Armen Hareyan on May 31, 2008 - 11:18am 
for eMaxHealth
for eMaxHealthThousands Of colorectal cancer patients benefit from Avastin-based therapy.
A wealth of new Avastin (bevacizumab) data will be presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago confirming that Avastin-based therapy is essential for patients with metastatic colorectal cancer (CRC). In total 15 separate data presentations will be made with highlights including:
1.
Source:
Roche eMaxHealth welcomes yourcomments and feedback on this story without registration, but keep the comments meaningful please. Links are not accepted.
